Suppressor of cytokine signaling-1 inhibits caspase activation and protects from cytokine-induced beta cell death

Pancreatic beta cell damage caused by pro-inflammatory cytokines interleukin-1β (IL-1β), interferon-γ (IFNγ) and tumor necrosis factor-α (TNFα) is a key event in the pathogenesis of type 1 diabetes. The suppressor of cytokine signaling-1 (SOCS-1) blocks IFNγ-induced signaling and prevents diabetes in the non-obese diabetic mouse. Here, we investigated if SOCS-1 overexpression in primary beta cells provides protection from cytokine-induced islet cell dysfunction and death. We demonstrate that SOCS-1 does not prevent increase in NO production and decrease in glucose-stimulated insulin secretion in the presence of IL-1β, IFNγ, TNFα. However, it decreases the activation of caspase-3, -8 and -9, and thereby, promotes a robust protection from cytokine-induced beta cell death. Our data suggest that SOCS-1 overexpression may not be sufficient in preventing all the biological activities of IFNγ in beta cells. In summary, we show that interference with IFNγ signal transduction pathways by SOCS-1 inhibits cytokine-stimulated pancreatic beta cell death.     

Cytomegalovirus infection blocks apoptosis in cancer cells

Recent pathological findings reveal a higher frequency of human cytomegalovirus (HCMV) in tumor cells from different tumors compared with surrounding tissues. Experimental investigations suggest possible supportive effects of HCMV for tumor development and progression. One HCMV effect on tumor cells is the inhibition of apoptosis, leading to the promotion of tumor cell survival. Decreased sensitivity to treatment-induced tumor cell death is a major reason for failure of anticancer chemotherapy. HCMV infection interferes with both the intrinsic and extrinsic cellular apoptosis pathways. HCMV promotes cell survival signaling influencing the tumor suppressor p53 and its relative p73, and stimulates the antiapoptotic Ras/Raf/MEK/Erk- and PI-3K-signaling pathways. Antiapoptotic effects mediated by HCMV are inhibited by antiviral treatment in cell culture. Therefore, a better understanding of the influence of HCMV infection on tumor cell apoptosis might translate into improved anti-cancer therapy.Received 10 November 2003; received after revision 22 December 2003; accepted 14 January 2004     

Effect of sodium butyrate in combination with prostaglandin E1 and inhibitors of cyclic nucleotide phosphodiesterase on human amelanotic melanoma cells in culture

Summary Sodium butyrate and cyclic AMP-stimulating agents (prostaglandin E₁, papaverine, theophylline, and RO20-1724) caused reductions in the cell number (primarily due to reduction in cell division) when added individually to human melanoma cells in culture. However, the combination of sodium butyrate with one of the cyclic AMP-stimulating agents produced a marked reduction in cell number (primarily due to cell death).Supported in part by BRSG grant RR-05357 awarded by Biomedical Research Support Grant Program, Division of Research Resources, National Institutes of Health. We thank Marianne Gaschler for her technical help.     

Indole-3-carbinol enhances ultraviolet B-induced apoptosis by sensitizing human melanoma cells

Indole-3-carbinol (I3C) has been found to act against several types of cancer, while ultraviolet B (UVB) is known to induce the apoptosis of human melanoma cells. Here, we investigated whether I3C can sensitize G361 human melanoma cells to UVB-induced apoptosis. We examined the effects of combined I3C and UVB (I3C/UVB) at various dosages. I3C (200 μM)/UVB (50 mJ/cm²) synergistically reduced melanoma cell viability, whereas I3C (200 μM) or UVB (50 mJ/cm²), separately, had little effect on cell viability. DNA fragmentation assays indicated that I3C/UVB induced apoptosis. Further results show that I3C/UVB activates caspase-8, −3, and Bid and causes the cleavage of poly(ADP-ribose) polymerase. Moreover, I3C decreased the expression of the anti-apoptotic protein, Bcl-2, whereas UVB increased the translocation of Bax to mitochondria. Thus, an increased Bax/Bcl-2 ratio by I3C/UVB may result in melanoma apoptosis. In conclusion, our study demonstrated that I3C sensitizes human melanoma cells by down-regulating Bcl-2. Received 5 July 2006; received after revision 25 August 2006; accepted 11 September 2006     

Effect of sodium butyrate in combination with prostaglandin E1 and inhibitors of cyclic nucleotide phosphodiesterase on human amelanotic melanoma cells in culture.

Sodium butyrate and cyclic AMP-stimulating agents (prostaglandin E1, papaverine, theophylline, and RO20-1724) caused reductions in the cell number (primarily due to reduction in cell division) when added individually to human melanoma cells in culture. However, the combination of sodium butyrate with one of the cyclic AMP-stimulating agents produced a marked reduction in cell number (primarily due to cell death).     

Mycobacterial lipoarabinomannans modulate cytokine production in human T helper cells by interfering with raft/microdomain signalling

Lipoarabinomannans (LAMs) are major lipoglycans of the mycobacterial envelope and constitute immunodominant epitopes of mycobacteria. In this paper, we show that mannose-capped (ManLAM) and non-mannose- capped (PILAM) mycobacterial lipoglycans insert into T helper cell rafts without apparent binding to known receptors. T helper cells modified by the insertion of PILAM responded to CD3 cross-linking by decreasing type 1 (IL-2 and IFN-) and increasing type 2 (IL-4 and IL-5) cytokine production. Modification by the mannose-capped ManLAMs had similar, but more limited effects on T helper cell cytokine production. When incorporated into isolated rafts, PILAMs modulated membrane-associated kinases in a dose-dependent manner, inducing increased phosphorylation of Src kinases and Cbp/PAG in Th1 rafts, while decreasing phosphorylation of the same proteins in Th2 rafts. Mycobacterial lipoglycans thus modify the signalling machineries of rafts/microdomains in T helper cells, a modification of the membrane organization that eventually leads to an overall enhancement of type 2 and inhibition of type 1 cytokine production.Received 9 September 2004; received after revision 14 October 2004; accepted 11 November 2004A. K. Shabaana and K. Kulangara made equal contributions to this work.     

Recruitment of Pyk2 to SHPS-1 signaling complex is required for IGF-I-dependent mitogenic signaling in vascular smooth muscle cells

In vascular smooth muscle cells, IGF-I stimulates SHPS-1/SHP2/Src complex formation which is required for IGF-I-stimulated cell proliferation. Using SHP2/Src silencing and a Pyk2/Y402F mutant, we showed that Pyk2 was also recruited to the SHPS-1 complex. Pyk2 recruitment to SHPS-1 is mediated via the interaction of Pyk2 Tyr402 and the Src in response to IGF-I. Following Src/Pyk2 association, Src phosphorylates Pyk2 on Tyr881 providing a binding site for Grb2. Cells expressing Pyk2/Y881F showed decreased Grb2 recruitment to SHPS-1 and impaired Shc/Grb2 association. This change led to reduced Erk1/2 (MAP kinase) activation and cell proliferation in response to IGF-I. Our results show that, following its recruitment to the SHPS-1 signaling complex, Pyk2 localizes Grb2 in close proximity to Shc thereby facilitating Shc/Grb2 association which leads to Erk1/2 activation in response to IGF-I. Thus, Pyk2 recruitment to SHPS-1 plays an important role in regulating the IGF-I-stimulated mitogenic response.     

The mode of timing of DNA replication and of mitosis in cultured animal cells

Zusammenfassung Eine indirekte Methode der Analyse des mitotischen Zell-Zyklus wurde an verschieden rasch, jedoch stets exponentiell wachsenden Suspensions-Kulturen von neoplastischen Maus-Mast-Zellen des Stammes P815Y und Kulturen von L929 Maus-Zellen geprüft. Die experimentellen Kurven (Dauer derG2-periode als Funktion der Kulturen-Verdopplungszeit, mitotischer Index als Funktion der spezifischen Wachstumsgeschwindigkeit der Kulturen, und DNA-synthetischer Index als Funktion der spezifischen Wachstumsgeschwindigkeit) sind mit der Hypothese im Einklang, nach der die Dauern derG1-,S-,G2- und derM-Periode homogen-lineare Funktionen der Generationsdauer respektive der Gesamtdauer des Zell-Zyklus sind. Demzufolge sind unter Bedingungen streng exponentiellen Kulturenwachstums die DNA-Synthese-Periode, dieG2-Periode und die Mitose-Periode nicht von konstanter Dauer, wie üblicherweise angenommen wird. Die experimentell erzwungene Verlängerung oder Verkürzung der Generationsdauer der sich in der Kultur teilenden Zellen (R-Zellen) wird somit nicht allein durch dieG1-Periode bestimmt, sondern durch gleichzeitige und prozentual gleichmässige Expansion oder Kontraktion aller vier charakteristischen Phasen des Zell-Zyklus.

---

---

This investigation was supported by the Office of Naval Research under contract No. Nonr-266(76) and by the Health Research Council of the City of New York under contract No. I-428, and was carried out at Columbia University (Department of Biochemistry).

---

Recipient of Career Scientist Award of the Health Research Council of the City of New York under contract No. I-428.

---

This paper has been dedicated to my former teacher Prof.Ad. Portmann on the occasion of his 70th birthday.     

Onset of mitosis after cell cycle blockage induced by cycloheximide in root tip cells

Summary The cells in S-phase at the time of a short treatment with cycloheximide, inducing reversible arrest of the cell cycle, enter mitosis before those in G₂ and are divided into 2 subpopulations when cell proliferation resumes.This work was supported by AI 031871 from the Centre National de la Recherche Scientifique and the University René Descartes, Paris.     

Migration of lymphoid cells to the bone marrow of rat following eradication of cells in DNA synthesis and in mitosis

Summary Eradication of replicating bone marrow cells of rat by means of combined administration of single doses of hydroxyurea and vinblastin is followed within 9–10 h by an inflow of lymphoid cells of extramedullary origin in the range of 13,200,000/femur. The rat bone marrow with a high content of lymphoid cells was previously shown to be concentrated in stem cells. The factor(s) which convey the information of decrease of replicating marrow cells to extramedullary sites is at present unknown.Acknowledgment. This study was supported by a grant from the Chief Scientist Office, Ministry of Health, Israel.Hydroxyurea for this investigation was given as a gift by the Squibb Institute of Medical Research, Princeton, N.J. USA, to which the authors are indebted.     

Opposite pattern of MDR1 and caveolin-1 gene expression in human atherosclerotic lesions and proliferating human smooth muscle cells

Cholesterol esterification and smooth muscle cell (SMC) proliferation are the crucial events in the development of atherosclerotic lesions. The objective of this study was to analyse cholesterol esterification and the expression of MDR1 (multidrug resistance), ACAT (acyl-CoA:cholesterol acyltransferase) and caveolin-1 genes in atherosclerotic and healthy vascular walls, in SMCs obtained from atherosclerotic lesions and saphenous veins. Results demonstrated higher levels of cholesterol esters, ACAT and MDR1 mRNAs and lower levels of caveolin-1 mRNA in atherosclerotic segments compared to adjacent serial sections of the same artery and the corresponding non-atherosclerotic arteries from cadaveric donors. SMCs isolated from atherosclerotic plaques manifested an increased capacity to esterify cholesterol and to grow at a faster rate than SMCs isolated from saphenous veins. In addition, when SMCs from atherosclerotic plaques were cultured in the presence of progesterone, a potent inhibitor of cholesterol esterification, significant growth suppression was observed. An increase in ACAT and MDR1 expression and a concomitant decrease in caveolin-1 expression were also observed in SMCs isolated from atherosclerotic arteries as early as 12 h after serum stimulation. An opposite pattern was found when SMCs were treated with progesterone. These findings support the idea that cholesterol esterification plays a role both in early atherogenesis and in clinical progression of advanced lesions and raise the possibility that the cholesterol ester pathway might directly modulate the proliferation of SMCs. Received 5 February 2001; received after revision 15 May 2001; accepted 15 May 2001     

si—DNMT1对肝门部胆管癌细胞抑癌基因甲基化的作用

目的研究RNA干扰对肝门部胆管癌细胞株QRC939抑癌基因甲基化的影响,初步探谤其在胆管癌治疗中的价值。方法构建靶向hDNMT1的发夹式siRNA表达载体;运用脂质体介导法将其转染人胆管癌细胞QBC939;RT-PCR法检测不同时间点hDNMT1、CDH1、p15的表达水平;MSP方法检测转染前后抑癌基因CDH1、p15的甲基纯状态;MTT检测各组细胞的增殖能力。结果1）hDNMT1的基因沉默恢复了抑癌基因CDH1、p15的表达水平;2）CDH1、p15的表达沉默是由启动子高甲基亿导致的;3）转染靶向hDNMT1的发夹式siRNA表达载体能有效地抑制QBC939的增殖能力。结论靶向hDNMT1的发夹式siRNA表达载体能有效、持续、稳定发挥对hDNMT1的基因沉默作用,恢复抑癌基因CDH1、p15的表达水平,从而抑制QBC939肿瘤细胞增殖。